Juhi Mehta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Juhi Mehta has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Anushree Agarwal
Division of Cardiology, Department of Medicine, University of California, San Francisco, CA (A.A., J.V., L.A.).
2 shared publications - Karina Buenrostro
Department of Medicine, Division of Cardiology, University of California, San Francisco, San Francisco, Ca, United States
2 shared publications - Katelyn Macholl
Department of Medicine, Division of Cardiology, University of California, San Francisco, San Francisco, Ca, United States
2 shared publications - Kevin Sun
Division of Cardiology, Department of Medicine, University of California, San Francisco, CA
2 shared publications - Megumi Okumura
General Internal Medicine and PRL Institute for Health Policy Studies, Departments of Pediatrics and Internal Medicine, Division of General Pediatrics, University of California, San Francisco, San Francisco, United States
2 shared publications - Pranav Ahuja
Department of Medicine, Division of Cardiology, University of California, San Francisco, San Francisco, Ca, United States
2 shared publications
Latest Publications
- 2 November 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
ACHD Care Wheel: A Stakeholder- and Theory-Driven Framework to Improve Specialized Adult Congenital Heart Disease Care
Background: Patients with adult congenital heart disease (ACHD) experience significant gaps in guideline-recommended care, associated with higher morbidity and mortality compared to those without care gaps. We evaluated barriers and facilitators to specialized care to inform patient-centered solutions. Methods: We purposively sampled ACHD patients and clinicians from UCSF and across the United States and conducted semi-structured interviews in 2023-2024. Patients were ≥18 years, spoke English or Spanish, and could provide informed consent; clinicians were cardiologists or other staff involved in ACHD care. Zoom interviews were conducted using Capability, Opportunity, Motivation, and Behavior (COM-B)-informed guides and were recorded, professionally transcribed, and translated when applicable. Data were analyzed using inductive coding and rapid qualitative analysis, with independent dual coding, consensus resolution, concurrent analysis, and member checking. Identified categories were subsequently mapped to the Theoretical Domains Framework and COM-B. Results: We interviewed 54 participants (37 patients, 17 clinicians). For patients, the median age was 32 years; 57% were women, 62% were people of color, and 35% had gaps in care of ≥3 years. Findings were organized into six interdependent categories: healthcare system and institutional structure; knowledge and education; sources of support; personal development; identity and personal resources; and ACHD’s placement in one's life. Two novel findings emerged: a paradoxical facilitating role of parental language barriers and the complex impact of caregiver support on patients' independent care skills. We developed the ACHD Care Wheel, a theory-guided framework to support the design and evaluation of future interventions. Conclusions: The ACHD Care Wheel is a stakeholder-derived, theory-grounded framework for developing and evaluating interventions to improve ACHD care. Interventions targeting the three priority categories (healthcare system and institutional structure, knowledge and education, and sources of support) are likely to produce effects across multiple domains simultaneously, offering a theoretically grounded path forward for this growing population.
- 2 November 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
ACHD Care Wheel: A Stakeholder- and Theory-Driven Framework to Improve Specialized Adult Congenital Heart Disease Care
Background: Patients with adult congenital heart disease (ACHD) experience significant gaps in guideline-recommended care, associated with higher morbidity and mortality compared to those without care gaps. We evaluated barriers and facilitators to specialized care to inform patient-centered solutions. Methods: We purposively sampled ACHD patients and clinicians from UCSF and across the United States and conducted semi-structured interviews in 2023-2024. Patients were ≥18 years, spoke English or Spanish, and could provide informed consent; clinicians were cardiologists or other staff involved in ACHD care. Zoom interviews were conducted using Capability, Opportunity, Motivation, and Behavior (COM-B)-informed guides and were recorded, professionally transcribed, and translated when applicable. Data were analyzed using inductive coding and rapid qualitative analysis, with independent dual coding, consensus resolution, concurrent analysis, and member checking. Identified categories were subsequently mapped to the Theoretical Domains Framework and COM-B. Results: We interviewed 54 participants (37 patients, 17 clinicians). For patients, the median age was 32 years; 57% were women, 62% were people of color, and 35% had gaps in care of ≥3 years. Findings were organized into six interdependent categories: healthcare system and institutional structure; knowledge and education; sources of support; personal development; identity and personal resources; and ACHD’s placement in one's life. Two novel findings emerged: a paradoxical facilitating role of parental language barriers and the complex impact of caregiver support on patients' independent care skills. We developed the ACHD Care Wheel, a theory-guided framework to support the design and evaluation of future interventions. Conclusions: The ACHD Care Wheel is a stakeholder-derived, theory-grounded framework for developing and evaluating interventions to improve ACHD care. Interventions targeting the three priority categories (healthcare system and institutional structure, knowledge and education, and sources of support) are likely to produce effects across multiple domains simultaneously, offering a theoretically grounded path forward for this growing population.
- Top Cited PapersOpen Access
- 23 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e75867
Digital Health Intervention to Promote Lifelong Specialized Care in Adults With Congenital Heart Disease: Theory-Driven Community Co-Designed Study
Background: Adults with congenital heart disease frequently experience gaps in lifelong adult congenital heart disease (ACHD) specialty care, leading to preventable complications, hospitalizations, and premature mortality. However, effective, scalable, accessible, and sustainable strategies to reduce these gaps are lacking. Digital health offers potential solutions but requires a rigorous scientific approach in its design to address the needs of the target population. Objective: This study aims to describe the development of a theory-based, community co-designed digital health intervention to improve lifelong ACHD care. Methods: We integrated theory-based behavioral frameworks, semistructured qualitative interviews with patients and clinicians, and a community-engaged approach to develop a digital health intervention for ACHD. The primary behavioral target was completing an ACHD specialist appointment. We conducted Capability, Opportunity, Motivation, and Behavior (COM-B)–guided semistructured interviews with patients with ACHD and clinicians to identify barriers to specialized care amenable to a digital intervention, and patient-centered goals for the digital tool. The community partners helped develop key intervention objectives, create a theory-driven framework, and specify how each intervention component targets specific COM-B barriers. Results: We interviewed 54 participants (n=37 patients with ACHD, and n=17 clinicians) and engaged 21 community partners representing 4 advocacy organizations. Design objectives emphasized addressing patient loneliness, ensuring accessibility and credibility, and enabling scalability while centering patient perspectives. Participants identified 4 priorities: providing credible resources, uplifting patient voices, customizing to patient needs, and centering positivity and joy. The digital tool, named by community partners as Empower My Congenital Heart (EMCH), was designed within the web- and mobile-based, Apple- and Android-compatible, Eureka Digital Research platform (University of California, San Francisco). Key intervention components included educational modules, peer support, appointment planning nudges, and a digital medical passport. The EMCH’s theory-driven framework specifies how each intervention component targets specific COM-B barriers to specialized ACHD care. Conclusions: The theory-driven, community co-designed EMCH digital tool provides a scalable approach to promote lifelong ACHD specialist care. Ongoing process evaluation and a planned randomized controlled trial will assess acceptability, engagement, and effectiveness in reducing care gaps. If proven effective, EMCH has the potential to prevent complications, emergency hospitalizations, and mortality affecting the majority of adults with congenital heart disease.
- 23 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e75867
Top Cited PapersOpen AccessDigital Health Intervention to Promote Lifelong Specialized Care in Adults With Congenital Heart Disease: Theory-Driven Community Co-Designed Study
Background: Adults with congenital heart disease frequently experience gaps in lifelong adult congenital heart disease (ACHD) specialty care, leading to preventable complications, hospitalizations, and premature mortality. However, effective, scalable, accessible, and sustainable strategies to reduce these gaps are lacking. Digital health offers potential solutions but requires a rigorous scientific approach in its design to address the needs of the target population. Objective: This study aims to describe the development of a theory-based, community co-designed digital health intervention to improve lifelong ACHD care. Methods: We integrated theory-based behavioral frameworks, semistructured qualitative interviews with patients and clinicians, and a community-engaged approach to develop a digital health intervention for ACHD. The primary behavioral target was completing an ACHD specialist appointment. We conducted Capability, Opportunity, Motivation, and Behavior (COM-B)–guided semistructured interviews with patients with ACHD and clinicians to identify barriers to specialized care amenable to a digital intervention, and patient-centered goals for the digital tool. The community partners helped develop key intervention objectives, create a theory-driven framework, and specify how each intervention component targets specific COM-B barriers. Results: We interviewed 54 participants (n=37 patients with ACHD, and n=17 clinicians) and engaged 21 community partners representing 4 advocacy organizations. Design objectives emphasized addressing patient loneliness, ensuring accessibility and credibility, and enabling scalability while centering patient perspectives. Participants identified 4 priorities: providing credible resources, uplifting patient voices, customizing to patient needs, and centering positivity and joy. The digital tool, named by community partners as Empower My Congenital Heart (EMCH), was designed within the web- and mobile-based, Apple- and Android-compatible, Eureka Digital Research platform (University of California, San Francisco). Key intervention components included educational modules, peer support, appointment planning nudges, and a digital medical passport. The EMCH’s theory-driven framework specifies how each intervention component targets specific COM-B barriers to specialized ACHD care. Conclusions: The theory-driven, community co-designed EMCH digital tool provides a scalable approach to promote lifelong ACHD specialist care. Ongoing process evaluation and a planned randomized controlled trial will assess acceptability, engagement, and effectiveness in reducing care gaps. If proven effective, EMCH has the potential to prevent complications, emergency hospitalizations, and mortality affecting the majority of adults with congenital heart disease.
- Open Access
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Boundary complexity of cortical and subcortical areas predicts deep brain stimulation outcomes in Parkinson’s disease
While deep brain stimulation (DBS) remains an effective therapy for Parkinson’s disease (PD), sources of variance in patient outcomes are still not fully understood, underscoring a need for better prognostic criteria. Here, we leveraged routinely collected T1-weighted (T1-w) magnetic resonance imaging (MRI) data to derive patient-specific measures of brain structure and evaluate their usefulness in predicting changes in PD medications in response to DBS. Preoperative T1-w MRI data from 231 patients with PD were used to extract regional measures of fractal dimension (FD), sensitive to the structural complexities of cortical and subcortical brain. FD was validated as a biomarker of PD progression through comparison of patients with PD and healthy controls (HCs). This analysis revealed significant group differences in FD across nine brain regions, including frontal, occipital, insular, and basal ganglia areas, which supports its utility as a marker of PD. We evaluated the impact of adding imaging features (FD) to a clinical model that included demographics and clinical parameters (age, sex, total number and location of DBS electrodes), and preoperative motor response to levodopa. This model aimed to explain variance and predict changes in medication following DBS. Regression analysis revealed that inclusion of the FD of distributed brain areas correlated with post-DBS reductions in medication burden, explaining an additional 13.6% of outcome variance (R2 = 0.388) compared to clinical features alone (R2 = 0.252). Hypergraph-based classification learning tasks achieved an area under the receiver operating characteristic curve of 0.64 when predicting with clinical features alone, versus 0.76 when combining clinical and imaging features. These findings demonstrate that PD effects on brain morphology linked to disease progression influence DBS outcomes. The work also highlights FD as a potentially useful imaging biomarker to enhance DBS candidate selection criteria for optimized treatment planning.
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Open AccessBoundary complexity of cortical and subcortical areas predicts deep brain stimulation outcomes in Parkinson’s disease
While deep brain stimulation (DBS) remains an effective therapy for Parkinson’s disease (PD), sources of variance in patient outcomes are still not fully understood, underscoring a need for better prognostic criteria. Here, we leveraged routinely collected T1-weighted (T1-w) magnetic resonance imaging (MRI) data to derive patient-specific measures of brain structure and evaluate their usefulness in predicting changes in PD medications in response to DBS. Preoperative T1-w MRI data from 231 patients with PD were used to extract regional measures of fractal dimension (FD), sensitive to the structural complexities of cortical and subcortical brain. FD was validated as a biomarker of PD progression through comparison of patients with PD and healthy controls (HCs). This analysis revealed significant group differences in FD across nine brain regions, including frontal, occipital, insular, and basal ganglia areas, which supports its utility as a marker of PD. We evaluated the impact of adding imaging features (FD) to a clinical model that included demographics and clinical parameters (age, sex, total number and location of DBS electrodes), and preoperative motor response to levodopa. This model aimed to explain variance and predict changes in medication following DBS. Regression analysis revealed that inclusion of the FD of distributed brain areas correlated with post-DBS reductions in medication burden, explaining an additional 13.6% of outcome variance (R2 = 0.388) compared to clinical features alone (R2 = 0.252). Hypergraph-based classification learning tasks achieved an area under the receiver operating characteristic curve of 0.64 when predicting with clinical features alone, versus 0.76 when combining clinical and imaging features. These findings demonstrate that PD effects on brain morphology linked to disease progression influence DBS outcomes. The work also highlights FD as a potentially useful imaging biomarker to enhance DBS candidate selection criteria for optimized treatment planning.